Evidence map›Paper›PMID 33897820›Full record

ArticleEvolutionary applications2021

Design and analysis of CRISPR-based underdominance toxin-antidote gene drives.

Jackson Champer, Samuel E Champer, Isabel K Kim, Andrew G Clark, Philipp W Messer

Open access · goldAbstract read
In one paragraph

Article in Evolutionary applications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 58 citations in OpenAlex.

  1. Long-term stability and performance of Cas9/guide RNA-based gene drives in anopheline mosquitoes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jackson ChamperDepartment of Computational Biology Cornell University Ithaca New York USA.ORCID https://orcid.org/0000-0002-3814-3774
Samuel E ChamperDepartment of Computational Biology Cornell University Ithaca New York USA.
Isabel K KimDepartment of Computational Biology Cornell University Ithaca New York USA.
Andrew G ClarkDepartment of Computational Biology Cornell University Ithaca New York USA.
Philipp W MesserDepartment of Computational Biology Cornell University Ithaca New York USA.ORCID https://orcid.org/0000-0001-8453-9377
Cornell University · US

Funding

Improved methods for inference of genotype-specific response to environmental toxinsR01ES029929 · NIEHS · PRINCETON UNIVERSITY · PI AYROLES, JULIEN, CLARK, ANDREW G · 2019 to 2023
$3.6M
Evolutionary dynamics of CRISPR gene drives in natural populationsR01GM127418 · NIGMS · CORNELL UNIVERSITY · PI MESSER, PHILIPP W · 2018 to 2022
$1.6M
Improving the efficiency and control of CRISPR/Cas9 gene drive systemsR21AI130635 · NIAID · CORNELL UNIVERSITY · PI CLARK, ANDREW G, MESSER, PHILIPP W · 2017 to 2018
$431k
Dynamics of Gene Drives in Natural PopulationsF32AI138476 · NIAID · CORNELL UNIVERSITY · PI CHAMPER, JACKSON · 2018 to 2020
$192k
NIAID NIH HHS F32 AI138476NIAID NIH HHS R21 AI130635NIEHS NIH HHS R01 ES029929NIGMS NIH HHS R01 GM127418
6 · The paper itself

Abstract

CRISPR gene drive systems offer a mechanism for transmitting a desirable transgene throughout a population for purposes ranging from vector-borne disease control to invasive species suppression. In this simulation study, we assess the performance of several CRISPR-based underdominance gene drive constructs employing toxin-antidote (TA) principles. These drives disrupt the wild-type version of an essential gene using a CRISPR nuclease (the toxin) while simultaneously carrying a recoded version of the gene (the antidote). Drives of this nature allow for releases that could be potentially confined to a desired geographic location. This is because such drives have a nonzero-invasion threshold frequency required for the drive to spread through the population. We model drives which target essential genes that are either haplosufficient or haplolethal, using nuclease promoters with expression restricted to the germline, promoters that additionally result in cleavage activity in the early embryo from maternal deposition, and promoters that have ubiquitous somatic expression. We also study several possible drive architectures, considering both "same-site" and "distant-site" systems, as well as several reciprocally targeting drives. Together, these drive variants provide a wide range of invasion threshold frequencies and options for both population modification and suppression. Our results suggest that CRISPR TA underdominance drive systems could allow for the design of flexible and potentially confinable gene drive strategies.

Indexed as

confinementCRISPRgene drivegenetic engineeringmodelingtoxin‐antidoteunderdominance

Identifiers

PMID33897820
PMCPMC8061266
OpenAlexW3108813309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.